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Abstract
Background
Seasonal Malaria Chemoprevention (SMC) is currently recommended for children under
five in areas where malaria transmission is highly seasonal. We explored children’s caregiv-
ers’ and community health workers’ (CHWs) responses to an extended 5-month SMC
programme.
Methods
Thirteen in-depth interviews and eight focus group discussions explored optimal and subop-
timal ‘uptake’ of SMC to examine facilitators and barriers to caregivers’ uptake.
Results
There did not appear to be major differences between caregivers of children with optimal
and sub-optimal SMC uptake in terms of their knowledge of malaria, their perceptions of the
effect of SMC on a child’s health, nor their understanding of chemoprevention. Caregivers
experienced difficulty in prioritising SMC for well children, perceiving medication being for
treatment rather than prevention. Prior to the study, caregivers had become accustomed to
rapid diagnostic testing (RDT) for malaria, and therefore blood testing for malaria during the
baseline survey at the start of the SMC programme may have positively influenced uptake.
Facilitators of uptake included caregivers’ trust in and respect for administrators of SMC
(including CHWs), access to medication and supportive (family) networks. Barriers to
uptake related to poor communication of timings of community gatherings, travel distances,
absence during SMC home deliveries, and limited demand for SMC due to lack of previous
experience. Future delivery of SMC by trained CHWs would be acceptable to caregivers.
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Conclusion
A combination of caregivers’ physical access to SMC medication, the drug regimen, trust in
the medical profession and perceived norms around malaria prevention all likely influenced
caregivers’ level of uptake. SMC programmes need to consider: 1) developing supportive,
accessible and flexible modes of drug administration including home delivery and village
community kiosks; 2) improving demand for preventive medication including the harnessing
of learnt trust; and 3) developing community-based networks for users to support optimal
uptake of SMC.
Introduction
Background
Although there is evidence of decreasing malaria morbidity and mortality globally, malaria
remains an important contributor to child mortality in sub-Saharan Africa [1]. In Ghana, it
accounts for 38% of all outpatient illnesses, 35% of hospital admissions and 34% of all deaths
in children under five years [2]. Control strategies have included the use of insecticide-treated
nets, indoor residual spraying, prompt diagnosis and treatment with artemisinin-based combi-
nation therapy (ACT) and intermittent preventive treatment in pregnant women.
In 2012, the World Health Organization (WHO) recommended seasonal malaria chemo-
prevention (SMC) [3] for the control of malaria in children under five where malaria transmis-
sion is highly seasonal, primarily the Sahel sub-region of sub-Saharan Africa [4]. SMC is “the
intermittent administration of full treatment courses of an antimalarial medicine during the
malaria season to prevent malarial illness” [3] and is delivered up to four times at monthly
intervals during the peak malaria transmission period in the area. SMC has been proven to be
effective in reducing episodes of uncomplicated malaria and severe malaria by about 75% and
is cost-effective and safe [3]. Its delivery by community health workers (CHWs) has been
shown to be feasible and to increase uptake compared to clinic-based delivery [5].
Extended SMC programme
To date, trials of SMC have mostly been conducted in places with a short rainy season, and
there has consequently been uncertainty whether SMCmight also be beneficial in areas of an
extended malaria transmission [6–10]. In response, we undertook a trial of monthly SMC over
five months in an area of extended malaria transmission, in the Ashanti Region of Ghana [clini-
caltrials.gov identifier: NCT01651416], a predominantly rural area with moderately high malaria
transmission throughout the year. Although the extended SMC programme reduced malaria
incidence by around 40% during the rainy season, reflecting an important public health impact,
this efficacy was lower than seen elsewhere, and coverage of SMC was generally lower than in
countries where a shorter SMC programme was used [11].
Aim
To assess the acceptability of the extended SMC programme and identify facilitators and barri-
ers to caregivers’ uptake of SMC for their children, we conducted a qualitative study alongside
the trial. The five objectives were to understand caregivers’ (i) knowledge of malaria to deter-
mine whether it affects uptake of SMC, and to examine (ii) perceived effect of SMC on
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children’s health, (iii) experiences and attitudes concerning the concept of SMC, (iv) experi-
ences and attitudes concerning the regimen of the chemoprevention and in particular the
extended period of SMC delivery, and (v) preferred place of administration of SMC. We were
particularly interested in factors that may have facilitated caregivers accepting at least four of
the five SMC doses (termed optimal uptake).
Method
Study setting
The randomised controlled trial (RCT) was conducted in all 13 communities of the Kwaso
sub-municipality of the Ejisu-Juaben Municipality of the Ashanti Region of Ghana ([1]. Chil-
dren aged between three months and five years in July 2012, living in study communities
already providing home-based management of malaria (HMM) were enrolled in the study.
Between July and November 2012, children were given either five monthly SMC cycles consist-
ing of a single dose of sulfadoxine-pyrimethamine plus amodiaquine given over three days, or
matching placebos. During the first day of the first study month, the field team and CHWs
held a community gathering to recruit children to the study and administer the first of three
daily doses of SMC. Caregivers were required to self-administer the remaining doses of amo-
diaquine to their children over the following two consecutive days. Over the remaining four
subsequent months the study team and CHWs repeated this process of SMC administration.
However, for children whose carers did not attend a community gathering (fourth month
onwards), CHWs visited children at home to deliver the first daily dose. CHWs also visited the
children each month after day three of the dosing regimen to record any side-effects.
CHWs supported many health activities in the community, such as monthly child welfare
clinics, national immunization days, and administration of oral rehydration sachets for chil-
dren with diarrhoea, supervised by the health directorate of their district. CHWs are known to
the study communities through a Home Management of Malaria (the HMM programme
established in 2007. CHWs within the HMM programme are based at home, or at a known
location in their village. Using a standard algorithm the CHWs manage children seeking treat-
ment for fevers, or other symptoms, by immediate referral to a health facility or treated pre-
sumptively with artesunate-amodiaquine. Recently, rapid diagnostic tests (RDTs) were
introduced to the HMM programme, and case-management of confirmed malaria cases is
with artemether-lumefantrine (AL). Children with negative tests are referred to the health cen-
tre for further management. No conditions other than malaria were treated by the CHW dur-
ing the trial period; children with signs of severe disease or where malaria was excluded as a
cause of illness were referred to the health facility.
The 13 communities were divided into three groups for the qualitative study: peri-urban
communities with a health care facility (HCF), peri-urban communities with no HCF and
rural communities with no HCF. Two communities per group were randomly selected for
inclusion into the qualitative study. In-depth interviews (IDIs) with caregivers of children who
had received the active SMC, and focus group discussions (FGDs) with caregivers of children
who had received both active SMC and placebo, took place after the administration of the fifth
SMC dose (see Table 1). All participants were female. Caregivers of children enrolled into the
SMC trial were predominantly of Ashanti ethnicity (the remainder being of Ewe, Grumani
and Grushi ethnicity) and of Muslim or Christian faith.
Recruitment and sampling
Uptake was categorised into those participants who received at least four cycles of SMC (here-
after ‘optimal’ uptake, even though it is not ideal for children to miss any of the monthly SMC
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cycles) and those who received fewer than four cycles (hereafter ‘sub-optimal’ uptake). In each
of the six communities, three children with optimal uptake and three children with sub-opti-
mal uptake were randomly selected from each community, using the register list and the ran-
dom number function in Stata. CHWs in the six communities helped to locate the caregivers
of these children and invited them for interview. Thirteen caregivers (seven optimal and six
sub-optimal) across all communities presented and consented for interview, however no care-
givers with sub-optimal uptake from the ’rural community without HCF’ presented on the day
of interview, with CHWs reporting they were not available that day (see Table 1).
In addition to the SMC registers, the number of SMC cycles provided to each child was ver-
ified using the enrolment card when the caregiver attended the IDI. It was not possible to ver-
ify if caregivers had actually administered the two home doses each month, other than by self-
report, which may be prone to social desirability bias. The definition of uptake is, therefore,
strictly based on administration of the first dose of SMC and delivery of remaining tablets to
the caregiver.
One FGD, involving 8–11 caregivers, was held per community. These caregivers were ran-
domly selected from the list of those recruited for the RCT (after eliminating those that had
been selected for IDI), irrespective of the number of doses of SMC received by their child. Two
further FGDs were conducted with CHWs from all 13 communities involved in the SMC trial.
CHWs were distributed between the two groups such that no two persons in the group
belonged to the same community.
Data collection
Data was collected using semi-structured interview guides (developed by GA and RK) that
covered the scope of the research objectives. The guides were pre-tested prior to implementa-
tion and revised accordingly.
During January to February 2013, data was collected by the field team, comprising three
experienced local, female, public health facilitators/interviewers. Two interviewers facilitated
the FGDs and the third conducted the IDIs. All IDIs and FGDs were conducted in the local
dialect, Twi, at local community centres. IDIs took up to 20 minutes while FGD lasted an aver-
age of one hour. Interviews and group discussions were audio–recorded, translated and tran-
scribed into English and proof read by the field team. Transcripts were not returned to the
participants for comment or correction before analysis was conducted, due to logistical
constraints.
Table 1. Female caregivers and community health workers who took part in In-Depth Interviews or Focus Group Discussions.
Method Community characteristics SMC Uptake No. ID
13 In Depth Interviews with Caregivers Periurban villages with HCF  4 doses (optimal) 1A, 2A
Periurban village with HCF  3 doses (sub-optimal) 1B, 2B, 3B
Periurban village without HCF  4 doses (optimal) 1C, 2C
Periurban village without HCF  3 doses (sub- optimal) 1D, 2D, 3D
Rural village without HCF  4 doses (optimal) 1E, 2E, 3E
Rural village with HCF  3 doses (sub- optimal) -
6 Focus Group Discussions with Caregivers Rural village without HCF Varied uptake F1, F2, F3
Periurban village without HCF Varied uptake G1, G2
Periurban village with HCF Varied uptake H1
2 Focus Group Discussions with CHWs Community Health Workers (mixed villages) - CHW1, CHW2
doi:10.1371/journal.pone.0166951.t001
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Data entry and analysis
Two researchers (LB and GA) familiarised themselves with all transcripts before they were
uploaded into NVivo v10. Three researchers (LB, GA, and RK) independently open-coded 2
IDIs and 2 FGDs. The codes were then grouped by LB and arranged within an analytical
framework structured around the 5 categories that mirrored the pre-defined objectives of the
study. This analytical framework was populated through indexing transcripts into the agreed
codes. The framework was continually revised during this process by adding or refining the
name of existing codes. Changes to the codes were agreed with the study team. The data were
then charted into framework matrices to compare the characteristics of and differences
between participant groups for each category and to consider connections between categories
[12]. Iterative review, reflection and analysis of the matrices revealed a number of themes and
subthemes, which are detailed in Table 2.
Reflexivity
To reduce the impact of language, gender and cultural barriers, the field researchers were local
female researchers. To deepen insights and ensure findings reflected the research context, in
situ analyses were regularly reviewed by study team members who had undertaken the data
collection.
Ethical considerations
Both the RCT and this qualitative sub-study, including the consent procedures, were approved
by the ethics committees of the University of Leeds [Ref HSLTLM/11/034], the London School
of Hygiene and Tropical Medicine (LSHTM) (Ref 6194) and Komfo Anokye Teaching Hospi-
tal / School of Medical Sciences, Kumasi [Ref: CHRPE/AP/117/12]. LSHTMwas the trial spon-
sor. Consent was initially sought from participants at the beginning of the study. Information
about the RCT and qualitative sub-study was read and explained to the participants using the
participant information leaflet. Written consent to participate in the RCT and qualitative
study was then obtained and documented on pre-prepared consent forms using participants’
signature or thumb print. Participants were given a participant information leaflet to retain
which detailed what they had consented to including a potential invitation to participate in
interview and discussion at the end of the RCT. In appreciation of the lag between the begin-
ning of the RCT and the qualitative sub-study, verbal reconfirmation of consent was sought
from all participants and recorded on audio files before participation in IDIs and FGDs. All
participants were anonymized in transcription and, once transcribed, all audio data was
deleted.
Results
There were 6 major themes that came out of the study, namely malaria literacy, perceived
influence of SMC, trust, understanding of chemoprevention and treatment philosophy, access
to medication and dosing regime, and preferred distribution method (see Table 2). Within
these major themes were sub-themes which summarise our interpretation of the data and
which are discussed in detail under each major theme.
1. Malaria literacy
Knowledge regarding malaria was highly varied amongst respondents. The term malaria (in
English) was recognised by all caregivers and was often interchangeable with fever. Malaria
fever, sun fever, cold food fever, and hard work fever were agreed by all in one FGD to be the
Acceptability to Caregivers of Seasonal Malaria Chemoprevention Programme in Ghana
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Table 2. Results of the coding and framework analysis.
Categories of codes (mirroring pre-
defined objectives)
Codes (used in
Nvivo)
Themes (identified through
analysis of framework
matrix)
Sub-theme (detailed
aspects of themes)
Key findings (Interpretation)
Knowledge of malaria Malaria names Malaria Literacy The term ‘malaria’ is often used
interchangeably with ‘fever’
Malaria health effects Multiple causes of malaria Confusion over promoted health
messages
Malaria causes Risk aware Children are recognised as a
vulnerable group
Malaria seasons Prevention practices aware Behaviours reflect CHWs’ health
messages
Malaria vulnerability Prevention medication
unaware
Malaria-related health education may
not improve uptake of SMC
Malaria general
prevention in adults or
in general
Malaria general
prevention in children
Malaria prevention—
IPT experience
Malaria prevention—
IPT knowledge
Malaria treatment
seeking behaviour
Perceived effect of SMC on children’s
health
SMC good effects on
children
Perceived Influence of SMC Varied uptake and
interpretation of side-
effects
Uptake varied despite positive health
effects
SMC bad effects on
children
Supportive networks (f) Supportive assurances may
counteract negative influences
SMC effects on
caregivers
Non-health benefits Wider indirect benefits beyond child
health
Trust (facilitated uptake) Hierarchical trust (f) Caregivers sought government and
medical experts to sanction
medication
Trust in the status quo (f) CHWs are a conduit of that trust
A trust learnt though
experience (f)
Learnt trust and positive testimony
may encourage others
Experiences and attitudes concerning
the concept of SMC
Blood testing Understanding of
Chemoprevention and
Treatment Philosophy
Poor recall despite
experience
Purpose of SMC could be made more
clear and acceptable
Understanding SMC Medical testing seen as a
precursor to any
medication (b)
Caregivers conditioned to RDT and
medication to treat versus medication
to protect
CHWs’ role in SMC
trial
Medication for healthy
children a difficult concept
(b)
Challenge asking caregivers to re-
prioritise their time
Experiences and attitudes concerning
the regimen of the chemoprevention, in
particular the extended period of SMC
delivery
SMC reported dosage Access to Medication and
Dosing Regimen (was
sometimes challenging)
Three-day regimen may be
difficult to follow (b)
Close supervision of consumption
and /or a single day regimen may aid
uptake
SMC 3-day
adherence ease and
motivation
Five monthly cycles
acceptable
Desire to collect SMC
SMC 3-day
adherence challenges
and reasoning
Access (b) & (f) Limited communication of access and
restricted modes of access to
medication
SMC 5-month
adherence ease and
motivation
SMC 5-month
adherence challenges
and reasons
(Continued)
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same fever (G1). Additional local names were also used including ‘etiridii’ (CHW1, H1),
‘ebunu’ (2A, 2B, 2D, F2, H1, G2), and ‘yare fufuo’ meaning ‘white-disease’ (H1).
Reported physical symptoms attributed by caregivers to malaria included fever, chills, vom-
iting, diarrhoea, yellowish palms and yellowish urine, feeling weak and restless, bitterness in
the mouth and loss of appetite. CHWs also reported children may have joint pain, refuse
water, experience a loss of weight and fatigue and associated these with malaria. One caregiver
explained it ‘can cause your blood to reduce’ (H1) as a result of vomiting.
Almost two thirds of caregivers from villages with no HCF attributed malaria to a single
cause: the mosquito bite. In contrast four of the five respondents with a HCF considered multi-
ple aetiologies for malaria including the mosquito in addition to any of the following: mos-
quito eggs on food, exposure to extreme heat or a lack of sun, house flies, food preparation and
consumption, dirty water, personal hygiene, household hygiene, poor diet or volume of
consumption.
Most caregivers (in IDIs and FGDs) were aware of their heightened malaria risk during the
rainy season, learnt through distinct periods of increased malaria within their community dur-
ing changes in the weather, nature’s response to the season (F3) and changes to the farming
environment (H1, G1). Three caregivers associated malaria with the ‘sunny season’ (1C, 3E, 1B).
FGDs revealed further support for this (F1, G1, H1) explaining a reluctance to sleep under a net
(F1). The termmalaria was interpretable and may be linked to the believed causes of malaria.
(H1) ‘..when children walk in the sun during the dry season, by the time they come back
they would have become weak and leads to malaria.’
When asked about groups more at risk of getting malaria, all participants replied “children”.
Three respondents with no HCF also identified pregnant women, and another five respon-
dents also identified adults.
Table 2. (Continued)
Categories of codes (mirroring pre-
defined objectives)
Codes (used in
Nvivo)
Themes (identified through
analysis of framework
matrix)
Sub-theme (detailed
aspects of themes)
Key findings (Interpretation)
Preferred place of administration of
SMC
Proposed SMC law in
Ghana
Preferred distribution
method
Caregivers and CHWs give
little support for child
welfare clinics
Multiple mechanisms of delivery will
support users’ needs
Community meeting
point—merits
Caregivers and CHWs give
more support for
community gatherings and
home visits
Better communication and multiple
distribution methods would support
uptake
Community meeting
point—challenges
CHWs propose community
kiosks
Participants suggested meaningful
ways to improve delivery and
administration including Community
Kiosks staffed by CHWs.
Community weighing
centre—merits
CHWs to be trained
Community weighing
centre—challenges
Finances required to
resource CHWs to support
delivery
At home–merits
At home—challenges
Other Questions for the
Interviewer at the end
of interview
-
NB: [(f) = cited facilitator of uptake and (b) = cited barrier of uptake)]
doi:10.1371/journal.pone.0166951.t002
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(G2) ‘When you go to the hospital, you realise that there are a lot of children and pregnant
women compared to adults. You hardly see adults, except for the elderly (>70years (as defined
by H1)) but there are a lot of children.’
Malaria prevention practices reported by caregivers to protect the family involved diligent
bed net use (shaking bed net out, early sleeping), protective clothing, closed ventilation
indoors, and repellents inside the home, and ‘good environmental hygiene’ to manage ‘filth’,
‘dirt’, and ‘standing water’ outside the home. Caregivers’ knowledge of prevention practices
reflected the messages communicated by volunteer CHWs.
CHW 1: Respondent I. ‘We advise the parents to sleep in the nets, to sleep early, and the
children less than five years to sleep early. The pregnant women should also sleep early because
they are prone to having very severe malaria. We have to weed our backyard and also we
should not throw empty tins around. Instead, we can bury them so that the rains cannot collect
in them. All gutters should also be de-silted and drained so that they do not breed mosquitoes.’
These practices require caregivers to take personal responsibility for prevention of malaria
which both empowered and frustrated caregivers, who reported that they offer little in terms
of flexibility during evening routines and do not prevent a child from getting malaria if bitten
by a mosquito. As such, malaria remains a constant concern.
(H1) ‘..what worries a bit is that because the mother is still awake, the child will not go to bed
so even if you put on the protective clothing the mosquito will get some part of the body to bite.’
(1A) ‘For the children, I cannot really tell how to protect them because children are very dif-
ficult to control. In the evening, whilst you are inside, he may be outside. If he is asleep, a par-
ent can place him under the treated net but when you are outside working, he may also be
outside with you and during that time too the mosquitoes may bite them and so by the time
you go to the room to sleep, he might have already been bitten by the mosquitoes.’
Knowledge of malaria was not identified as an important determinant of SMC uptake,
because malaria literacy varied within uptake groupings. In communities with a HCF, despite
the opportunity for enhanced knowledge on health matters through contact with health work-
ers, caregivers lacked clarity over the causes of malaria. Nevertheless, even amongst caregiver
respondents who knew malaria’s true cause, or were specifically aware of children’s vulnerabil-
ity to malaria during the rainy season, uptake of SMC remained varied, indicating that
malaria-related health education may not improve uptake of SMC.
2. Perceived Influence of SMC
Caregivers reported SMC had positive health effects on their children. Caregivers who took
four or more monthly doses of SMC reported positive health effects (including no malaria,
reduced headaches and no sickness, ceased diarrhoea and no high body temperature) and
were motivated by these benefits to continue with taking the medicine (2E, 1A, 2A, 1C, 3B, 2C,
3E, 1C).
(2A) ‘Since I gave her the medicine, I saw a change in her condition and that was my
motivation.’
(1D) ‘We are grateful for this drug; you should thank them very much for us. It has saved
our children from sicknesses so they should continue with the programme and make the medi-
cines available to the children.’
Caregivers who took fewer than four monthly doses of SMC also noticed positive health
responses (including no or reduced episodes of malaria, reduced appetites and regained
strength) but despite realising these positive effects, these caregivers had sub-optimal uptake
(1B, 2B, 3B, 1D, 2D, 3D) suggesting other factors that influenced uptake. Reasons reported are
discussed in Section 5 and include complexity of the medication regimen and access.
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Three caregivers, two of whom took four or more monthly doses of SMC, reported tempo-
rary negative health effects including high body temperature, yellow urine and vomiting. Neg-
ative health effects did not stop some caregivers continuing with the medicine but may have
stopped one caregiver from taking the medicine believing her child had fallen ill after consum-
ing it (hearsay reported by 2B).
(2B) ‘A lady attested to the fact that her children fell ill after taking the medicine, so, she
stopped coming for it. My child did not have any problem with the medicine.’
Caregivers reporting they had continued giving their children the medicine, despite per-
ceived negative health effects, did so after receiving supportive counsel and encouragement
from wider family and CHWs. Informed and supportive assurances from respected peers
appeared to counteract some negative influences and may have aided uptake.
(1A) ‘His urine was very yellow so I went to see my grand-father and he asked me to keep
on giving him the drug and the sickness will go. And when I continued giving him the drug, I
did not see anything again.’
(3B) ‘I was not scared about my child vomiting. . .mymother motivated me; she said maybe
the child had a lot of malaria parasites in her system that is why she is vomiting.’
Caregivers reported other non-health benefits associated with SMC not related to child
health. When a child was well, caregivers did not need to travel to the hospital or drug store,
nor pay for treatment and laboratory costs. Their reported productivity–spending time work-
ing away from home or working on domestic chores at home–also increased. This resulted in
time and financial savings and reduced anxiety around child health and malaria. One caregiver
indicated her son of ‘school’ age (i.e. 3–5 years old and attending kindergarten) had improved
health, suggesting other possible indirect benefits.
(1C) ‘This one (my son) goes to school and always complained of headaches but ever since
I started giving this drug, he has not complained about the frequent headaches he used to have
so I know it has helped him a lot.’
(2D) ‘. . .it can give a measure of freedom to parents. . . as the burden of malaria on parents
is too much.’
3. Little understanding of chemoprevention
Caregivers found the concept of SMC (chemoprevention) difficult to understand and many
could not freely recall ‘any protection medicine for any group of people in Ghana to prevent
malaria’, despite their experience with intermittent preventive treatment (a malaria prophy-
laxis) during pregnancy, and their children’s participation in (and in some cases optimal
uptake of) SMC. Some caregivers reported the protection of children from malaria consisted
of regular blood checks for parasites and subsequent treatment.
(1A) ‘I cannot protect them unless there is a medicine that can reduce the malaria if the
child has it.’
Most caregivers (except 3B) required detailed explanation of the concept of ‘protection’ ver-
sus ‘treatment’. This helped some caregivers recall SMC when asked if there was a medicine to
protect children under five (2A, 1B, 2B, 3E). Explanation of preventive treatments taken dur-
ing pregnancy enabled interviewers to help others understand the difference between malaria
treatment medication and malaria prevention medication (1A, 2D, 1E). All respondents with a
HCF and only a third of respondents without a HCF could, after being prompted, recall SMC
and understand its function. Some respondents with sub-optimal uptake understood SMC,
suggesting other factors that influenced uptake.
Despite being enrolled in the SMC programme some caregivers remained unclear about its
purpose (1C, 2C, 1D, 3D, 2E). A few of these caregivers indicated they would welcome a
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conceptual medicine like SMC. However caregivers’ theoretical intentions may not reflect
behaviour in practice.
(1D) ‘Wherever that medicine is, they should get us some of it to protect our children from
malaria.’
Caregivers’ lack of understanding of the concept of SMC is further explained through their
opinions around taking medication in the absence of medical testing. Caregivers had mixed
reasoning as to the purpose of the initial blood test and the absence of subsequent blood tests
and these reasons may have influenced uptake of SMC in some caregivers; some caregivers were
cautious in taking SMC without additional testing. Where caregivers continued to accept subse-
quent doses of SMC some reasoned it was offered as a result of the child’s initial blood test.
(1C) ‘in my opinion, if the child does not have the malaria parasites and takes the (SMC)
medicines, it will bring problems to the child.’
(2C) ‘maybe they have seen some sickness in the blood and they made an announcement
that we should all come here. So we came.’
Without the blood test CHWs sometimes experienced difficulty in explaining to caregivers
why their children should take medicines if they are not sick. Instead some caregivers priori-
tised their time elsewhere e.g. attending to their work (CHW2). CHWs reported trying to
incentivise caregivers by reminding them about the blood test at the end of the rainy season to
allow them to establish if the medicine had worked.
(CHW1) ‘They asked us about the results of the first blood test that was done and wanted to
know what was wrong with their children. It was difficult for us to answer so we told them
that it had been sent to bigger machines to do the test and so later we would hear of the
results. And that at the last dosing too, their blood will be checked again to compare with the
first one to see if the medicine was helpful. So this is what we told them to encourage them to
come for subsequent doses because they wanted to know why the test was done and then the
child was given medicine.’
These reactions suggest caregivers’ understanding of chemoprevention varied amongst
respondents and, as with malaria literacy and the observed effect of SMC on a child’s health,
no clear differences were observed between those with and without optimal uptake.
4. Trust facilitated uptake
Caregivers who took and continued to take the medicine did so because they entrusted others
in the ‘protection’ of their child. Hierarchical trust in the medical profession and the govern-
ment, where medical and societal rules prevent harm being done to another [13], is one exam-
ple of trust.
(1C) ‘You are the doctors and so . . . if you do not check the blood and you say I should give
the medicine to my children I will go ahead and do that.’
(2D) ‘(They would not) give medicine to children with the aim of harming them.’
(3E) ’If you do not accept it you don’t have any medication for the child, so you have to
accept it just as you have been given.’
For CHWs and caregivers who understood chemoprevention, it was the combined pro-
cesses of SMC being ‘sanctioned’ by the government, the experience of taking medication
despite no further blood tests, and subsequent observations of no malaria that convinced par-
ticipants ‘the medicines were to protect the children from getting malaria not to treat the
malaria’ (CHW1). With this shared learning experience (a learnt trust) many of the caregivers
continued to obtain SMC for their children.
(2B) ’I will allow my child to take medicine. Since (the medicine) does not kill.’
(3B) ‘You need not take medicines only when you are ill.’
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Despite caregivers’ undeveloped understanding of the purpose of the SMC, their under-
standing learnt through experience and shared testimony may have created a snowball effect
and triggered other caregivers to trust the programme.
(CHW2) ‘..they have come to believe in the medicine so much. . . those who were not part
are now very serious and want to join in.’
Comments like this lead us to believe that SMC programmes may benefit from supportive
testimonies of caregivers who have previously received SMC, and if it is made clear govern-
ment and medical experts sanction that SMC.
5. Access to medication and dosing regimen
Caregiver respondents with optimal and sub-optimal uptake of SMC reported no challenges
associated with the SMC three-day regimen, were able to follow the regimen (3B), and
reported it was not difficult to administer to the child.
(3E) ‘If they say you should follow the directives and you don’t follow it, the medicine may
not work.’
(1C) ‘No it was not difficult to administer the medicines to them.’
However during household visits after the third day of each monthly SMC dose, the CHW
estimated (based on some caregivers having tablets remaining) that 10–20% of caregivers had
not given day two and day three of the monthly cycle (CHW 1). This suggests, as seen else-
where, that the three day per month dosing regimen may have been difficult for some caregiv-
ers to follow.
The five continuous monthly cycles were considered by all to be well spaced and easy to fol-
low. Caregivers were typically unaware of how many monthly doses they had collected but
believed they collected doses when informed by CHWs. CHWs reported that caregivers’
uptake was influenced by ineffective announcements to collect the medication where fixed-
point delivery was used, allocation times (1E) and absence of caregivers from home during
home delivery.
(1B) ‘I am not sure of the number of times I came for the medicine. I did come till they
stopped coming to distribute the medicines but I’ve not checked the number of times.’
(1B) ‘Yes she brought some to my home but she missed me.’
(2B) ‘Monthly intervals are spread out enough and so it is not disturbing.”
(2D) ‘I always come here for the medicine when called so maybe I did not come for it
because I was not called.’
Other reported barriers to uptake were having to walk to collect medication particularly
during hot days, the perception of the study being for research only rather than personal bene-
fit (CHW1), forgetfulness and laziness.
The fact that some caregivers were found to have not administered some tablets to their
children highlights the need for CHWs to check and encourage caregivers to administer the
full dose. CHWs proposed an extended seven month period to accommodate children in rural
areas with no HCF, suggesting May through November (CHW2). This proposal was also sup-
ported in the trial, with evidence that SMC started too late in 2012 relative to the start of the
long transmission season [11].
6. Preferred distribution method
Respondents were asked to comment on the distribution methods used to administer the SMC
during the trail. They were asked about their preferred method in addition to their opinion on
the hypothetical distribution of SMC through existing Child Welfare Clinics (CWC). Respon-
dents also identified a fourth potential distribution method; the creation of local kiosks.
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Child Welfare clinics (CWCs). CWCs were identified by some respondents as a good
place to administer SMC to children between the ages of 0-5years whose mothers attend regu-
larly. Here, it was believed trained medical staff had time to educate attendees, monitor child
development, and administer vaccinations.
(3E) ‘Lately they have added one injection at one and half years and the parents bring their
children for it.’
Despite having the infrastructure and staff expertise to administer SMC to all children
under five years, this option received most objections. Some caregivers had never been to the
CWC, or had stopped going after the child had received its last injection around nine months
(3B) or had outgrown the ‘weighing’ (2E). Some also found the nurses unapproachable (1D
and 2B).
From the caregivers’ perspective, the addition of an SMC programme to existing CWCs
had little support given current reluctance towards the continued use of this service after chil-
dren reached nine months of age. These findings suggest that additional support to capture
caregivers who did not or could not attend the CWC would be required.
Community gathering. Community gatherings were preferred by caregivers who had
become accustomed to this method during the trial (1C), or who preferred medication admin-
istered by medical staff (3D). Some felt empowered by actively collecting the medication at the
community gathering rather than waiting for a home delivery that ‘could be delayed’ (1B, 1D).
Not all caregivers heard about or were able to go to the public place announced and so this
approach may have failed to reach some participants.
Aspects such as being close (3D) to the community centre, being better advertised, having
enough water supplies to consume the medication–‘here the pipe is only one’ (2A)–and expo-
sure to medical staff would support the administration of SMC at community gatherings.
Household delivery. CHWs made announcements for caregivers to gather and collect
SMC and then delivered SMC to children in households whose caregivers did not attend.
Caregivers unable to collect medication appreciated the local (1C), explanatory (1C) and fam-
ily-focused delivery (3B) offered by CHWs. This mechanism extended uptake amongst care-
givers who were not reached by fixed-point delivery. CHWs would be unlikely however to
successfully deliver SMC to caregivers who were frequently absent from home because of work
commitments (e.g. farm workers and traders (3D)). Visiting homes at the close of the day may
be an alternative approach but presents its own challenges.
The CHWs believed they were more suitable administrators of the programme than the
CWC given their extensive knowledge of caregivers in the community and flexible working
hours and outreach capabilities. CHWs preferred full responsibility for the distribution of the
medicine so they could reach all households in a ‘systematic way’.
One caregiver preferred the medicine be administered by medical staff (3D) but most were
agreeable to administration by ‘trained’ CHWs. In some cases the CHWs were requested to
administer the medication to the child; either the caregiver had difficulty in getting their child
to take the medicine (3D), or simply because the caregiver entrusted responsibility to the per-
ceived ‘experts’. The CHWs accommodated the additional responsibility and administered the
medicine using a combination of gentle coercion, dissolving the medicine in water, and a ‘tof-
fee’ (CHW1 and CHW2) to motivate children who had difficulty in swallowing the ‘bitter
taste’ (CHW1).
Many households were remote and difficult to access in bad weather (3E). This approach
on its own would require a large and resourced task force to deliver, administer and follow up
with all households (1B, 3B). An agreement to leave medicine with non-primary caregivers
may support delivery of medication when primary caregivers are not home (3D), and medical
training of CHWs could offer reassurance to caregivers and further increase uptake (3D).
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Caregivers whose children had optimal uptake identified the community gatherings and
home delivery as their preferred mode of administration given the flexibility of these
approaches and respect for the medical staff and CHWs. Where a preference was stated, care-
givers whose children had suboptimal uptake also preferred these modes. For both modes of
administration, additional supportive resources relating to advertising the gatherings, and
remuneration of the CHWs specifically for SMC (in addition to their duties in HMM), would
support delivery of medication.
Community kiosks. It was proposed that local kiosks could be permanently stationed in
the community and would act as a reminder and distribution service. The kiosks would be dis-
tinct from the CHWs’ homes and ‘belong to the community’ (CHW2) triggering passing care-
givers to collect the medicine.
(CHW2) ‘Like lotto operators, everyone has their kiosk so on Saturdays everyone knows
that if they go to the kiosks, they can stake their lotto. We should get permanent posts like
small kiosks in the communities which are centres for children under five for everyone to
know. When the women pass by, they will see the kiosks and be reminded of coming to receive
the medicine for the children. They will know that there is a particular group of people at this
place who give medicines for free so will come.’
(CHW2) ‘The kiosks, as he said, are important such (that) we can dedicate specific weeks
for receiving the medicines. I think in this way, they will come for them.’
Incentives. It was reported that incentivising caregivers would support collection of SMC.
Incentives would take the form of a gift of tokens or small gifts such as soap. CHWs indicated
that the household or community administration of the medicines would further be improved
if they too were motivated through the following means: a formalised contract, remuneration
(such as 200 Ghana cedis/month), sanctioning from the government of their work and respon-
sibilities, and transport aids such as a bicycle or motorbike to cover the larger communities or
geographical areas.
Discussion
SMC has the potential to avert a large number of clinical malaria episodes during the malaria
transmission season [14], but only if SMC drugs reach caregivers and are correctly adminis-
tered. It is therefore essential to understand the acceptability of the extended SMC programme
and identify facilitators and barriers to caregivers’ uptake of SMC.
Acceptability
The length of the five month SMC programme was acceptable in principle to caregivers, albeit
many could not recall how many cycles they had had. Whilst caregivers reported the 3-day per
month regimen was also acceptable, in practice the full dose was not always consumed as evi-
denced by CHWs during home visits. The complexity of the regimen may have influenced
uptake and subsequent efficacy of the SMC [11]. It was widely recognised that a one day regi-
men would be preferable for SMC and would reduce the burden of drug administration on
caregivers.
Whilst the SMC programme sought to alleviate the risk of malaria in children it may not
have met the perceived needs of caregivers [15]. Caregivers believed there was no need to
medicate children who were well: conveyance of the reported non-health benefits associated
with SMC may widen appreciation of the medication. Experience of chemoprevention dur-
ing pregnancy had not accustomed caregivers to medication against their behavioural
norm, i.e. to medicate without clinical symptoms, testing and diagnosis, particularly against
a backdrop of Test Treat and Track for malaria [16]. A patient’s own decision-making
Acceptability to Caregivers of Seasonal Malaria Chemoprevention Programme in Ghana
PLOS ONE | DOI:10.1371/journal.pone.0166951 November 29, 2016 13 / 18
around treatment can be complex and challenging [17], as can that of a patient’s or child’s
caregiver [18] despite being ‘risk aware’, and motivated towards their welfare. Values such
as a caregiver’s priorities (work vs. ensuring a child is well), life philosophy (treat to pro-
tect), self-efficacy (perceived ability) and background (malaria is a risk presented to all) are
all likely to contribute to decision-making [17]. A combination of caregivers’ physical access
to SMC medication, self-belief in being able to effectively protect a child from malaria [19]
and perceived norms around malaria prevention are all likely to have influenced caregivers’
level of uptake.
Facilitators
There did not appear to be major differences between caregivers of children with optimal and
sub-optimal SMC uptake in terms of their knowledge of malaria, their perceptions of the effect
of SMC on a child’s health, nor their understanding of chemoprevention. In this study it was
not possible to identify how or if knowledge influenced respondents’ behaviour (i.e. optimal or
sub-optimal uptake) [12, 20], but other facilitators of uptake were suggested.
Reported facilitators of uptake included caregivers’ hierarchical trust and respect for medi-
cal experts and CHWs, supportive community networks that alleviated concerns about che-
moprevention, and learnt trust through experience of the SMC during the programme.
Caregivers had varied knowledge of malaria and its causes, and almost no knowledge of
chemoprevention despite the SMC programme and generally high use of Intermittent Preven-
tive Treatment in Pregnancy (ITPp) in the area [21]. An entrenched culture of trust can occur
where health awareness is poor, as seen in these villages. Loyalty, belief in the competency of
and respect for the medical professionals are dimensions of trust previously identified in
resource poor health care settings [22]. Caregivers’ comments imply an unwritten covenant
between government, medics and CHWs that protects the vulnerable. The caregivers’ trust
exhibits pre-defined expectations relating to non-exploitation and acquiescence. Caregivers’
trust in experts’ knowledge reduced the two-way participation in informed decision-making
seen in ‘developed countries’ [23–25] and has been identified elsewhere as a reason for initial
adoption of a new preventive medication [15, 26]. However, caregivers had some concerns
over the absence of regular blood tests, as they had become used to existing provision of RDT.
Extending caregivers’ trust to include chemoprevention is one area where trust could be
improved. CHWs may be key in offering that sense of social connectedness and familiarity,
which increases confidence, and trust in a programme [22], particularly important given care-
givers’ varied health literacy and lack of autonomy in health.
Some caregivers benefited from talking about the medication [21] to family members and
CHWs who reinforced the worth of the medication and gave them reassurance to continue.
Positive testimonies of the protective effect of the medication created a snowball effect and
triggered requests from the wider community to join the programme. Sensitisation meetings
that promote community understanding and involvement in drug administration pro-
grammes can maintain and increase uptake [27]. Recruitment and advocacy from clinicians
such as hospital workers (particularly those involved in IPTp and malaria treatment), drug
stores and third party local groups, and previous users of SMC would not only build buy-in
[28] amongst the health sector but offer wider more holistic support to the community.
Barriers
Barriers to uptake related to challenges around access to medication and dosing regimen to
reflect the preferred distribution method and the treatment philosophy of caregivers and
CHWs. Caregivers were less engaged in the nuances of malaria and preventive medication.
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Rather, access (communication and administration) to chemoprevention through the use of
flexible and accessible modes of administration (through home visits and fixed point provision
respectively) appeared preferable; other studies suggest this may give greater uptake [5] than
offering access through existing CWCs, whose use can be limited [29]. Caregivers may have
disconnected with the SMC programme as a result of inconvenient access to the SMC.
Restricting communication of the programme to participants to the use of local FM stations,
coupled with caregivers’ work commitments reduced attendance at community gatherings.
Community gatherings acted as a social and supportive opportunity to share experiences but
required better advertising to improve attendance and uptake. Household delivery was a more
flexible method as CHWs could operate flexible working hours. However appropriate trans-
port, training and remuneration would be required [15] to enable CHWs to access often hard
to reach households. Levels of optimal uptake may increase if the household delivery strategy
allowed medication to be left with any adult of a household in the absence of the primary care-
giver. The two modes could operate exclusively or jointly and be tailored to each village relative
to the funding and training needs of CHWs, and the distances and terrain covered by caregiv-
ers and CHWs. Pop-up community kiosks situated in communities could also encourage and
enable caregivers to collect the medication every month during the malarial season.
Caregivers could comprehend malaria treatment medication much better than malaria pre-
vention medication. Caregivers had, independently of the trial, been exposed to routine health
education whereby the reasons for children’s ill symptoms were screened using diagnostic
blood tests that revealed the presence or absence of malaria parasites prior to treatment. Dur-
ing the trial, blood samples were taken from participating children at the beginning of the
study, as part of a cross-sectional survey prior to the first cycle of SMC. All children (apart
from those who were unwell and who were referred for treatment) subsequently received SMC
or matching placebo. However, encouraging subsequent uptake of SMC in the absence of fur-
ther blood tests each month evoked discussion amongst caregivers who appeared conditioned
to take further malaria medication only after further testing. Whilst appropriate diagnosis and
treatment is important [22], the RDT programme may have acted as a barrier to sustained
uptake of chemoprevention amongst respondents; and this confusion about diagnostic testing
before treatment and no testing before prevention may have been compounded by the use of
diagnostic testing at the first cross-sectional survey.
Recommendations
The study identified the trust these communities place in the medical profession and the role
this plays in SMC uptake. The medical profession, in conjunction with local government, must
reflect how best to constructively use this trust to support optimal uptake. Cantey [30] recom-
mends piloted data such as this is used to inform and educate mass drug administration pro-
grammes. A targeted, clear and timely pre-SMC educational campaign that reflects the
facilitators and barriers to uptake amongst caregiver respondents (Table 3) would sensitise
and enable users to maximise uptake and associated health benefits offered by SMC. Such cam-
paigns are being implemented in more seasonal areas of West Africa where SMC is now being
implemented at scale.
SMC programmes need to consider 1) developing supportive, accessible and flexible modes
of drug administration including door-to-door delivery and fixed point distribution, 2)
improving demand for preventive medication including harnessing learnt trust in the medica-
tion which caregivers developed through their shared experiences during the programme, and
3) developing supportive community-based networks for users to encourage optimal uptake of
SMC.
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Table 3. Summary of faciltators and barriers to SMC uptake amongst caregiver respondents, col-
lected during a qualitative study in Ghana in January 2013.
Facilitators of SMC uptake Barriers to SMC uptake
• Trust in and respect for authorities who were seen
to sanction and implement the SMC
• SMC programme was incompatible with some
caregivers perceived needs, who believed there was
no need to medicate children who were not sick and
their time was better spent at work
• Proximity to and communication of fixed point
delivery (community gatherings)
• Large distances to travel, restricted timings of, and
poor communication of fixed point delivery
(community gatherings)
• Flexible door-to-door (household) delivery • Delivery of medication only to primary caregiver
during door-to-door visits
• Beliefs that any perceived side-effects of SMC
were attributable to the SMC medication treating
undiagnosed malaria in the child
• Beliefs that any perceived side-effects of SMC
were attributable to the SMC medication harming the
child
• CHW supervision and administration of medication
directly to the child at home.
• Need to consume all SMC medication over 3
consecutive days within a month.
• Reference to IPTp to explain the difference
between malaria treatment medication and malaria
prevention medication
• Caregivers found the concept of preventive
medication difficult to understand despite experience
of IPTp and the SMC programme
• Observation of other caregivers’ participation and
their perceived positive health responses
• Belief the intervention was for research only and
not routine care
• Reassurance from CHWs and senior family
members on perceived side-effects (the basis for a
supportive community-based network)
doi:10.1371/journal.pone.0166951.t003
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